POM

6-K - POMDOCTOR Ltd (0001877971) (Filer)

GUANGZHOU, China, June 17, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ:POM), a leading online medical services platform for chronic diseases in China, today announced that, as previously announced on May 28, 2026, the ratio change of its American depositary shares (the "ADSs") to Class A ordinary shares from the current ratio of one (1) ADS representing one-sixth (1/6) Class A ordinary share to a new ratio of one (1) ADS representing three (3) Class A ordinary shares (the "ADS Ratio Change") will become effective on June 22, 2026, U.S. Eastern Time (the "Effective Date"). For the Company's ADS holders, the ADS Ratio Change will have the same effect as a one-for-eighteen re

F-6 POS - POMDOCTOR Ltd (0001877971) (Subject)

6-K - POMDOCTOR Ltd (0001877971) (Filer)

GUANGZHOU, China, May 28, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ:POM), a leading online medical services platform for chronic diseases in China, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to its Class A ordinary shares (the "ADS Ratio Change"), from the current ratio of one (1) ADS representing one-sixth (1/6) Class A ordinary share to a new ratio of one (1) ADS representing three (3) Class A ordinary shares. For the Company's ADS holders, the ADS Ratio Change will have the same effect as a one-for-eighteen reverse ADS split. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with th

6-K - POMDOCTOR Ltd (0001877971) (Filer)

GUANGZHOU, China, May 14, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced its financial results for the fiscal year ended December 31, 2025. Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented: "Fiscal year 2025 marked a year of solid revenue expansion and continued execution of our growth strategy. Both our net revenues and gross profit recorded solid year-over-year increases, by 16.7% and 9.6% respectively, primarily driven by the strong growth of our Internet hospital business, particularly online pharmacy sales as we deepened collaborat

20-F - POMDOCTOR Ltd (0001877971) (Filer)

3 - POMDOCTOR Ltd (0001877971) (Issuer)

NT 20-F - POMDOCTOR Ltd (0001877971) (Filer)

6-K - POMDOCTOR Ltd (0001877971) (Filer)

3 - POMDOCTOR Ltd (0001877971) (Issuer)

6-K - POMDOCTOR Ltd (0001877971) (Filer)

3 - POMDOCTOR Ltd (0001877971) (Issuer)

3 - POMDOCTOR Ltd (0001877971) (Issuer)

3 - POMDOCTOR Ltd (0001877971) (Issuer)

3 - POMDOCTOR Ltd (0001877971) (Issuer)

3 - POMDOCTOR Ltd (0001877971) (Issuer)

GUANGZHOU, China, March 13, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ:POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track of "artificial intelligence ("AI") + medical-grade smart wearables + full-cycle chronic disease management". The Company plans to accelerate related technology research and development ("R&D") and scenario-based implementation by leveraging its extensive medical resources and strong compliance capabilities. Over the long run, Pomdoctor aims to build a closed-loop chronic disease management ecosystem integrating hardware, data, algorithms and servi

6-K - POMDOCTOR Ltd (0001877971) (Filer)

GUANGZHOU, China, Feb. 4, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ:POM), a leading online medical services platform for chronic diseases in China, today announced a strategic initiative to deepen the integration of its platform with China's national and local coordinated medical insurance systems across major cities nationwide. This initiative is expected to significantly expand the Company's market reach and enhance its service offerings, delivering greater convenience and richer functionality for partner internet hospitals, pharmacies, and patients. Since 2018, China has actively promoted internet-based medical services through a series of policy guide

6-K - POMDOCTOR Ltd (0001877971) (Filer)

GUANGZHOU, China, Feb. 2, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ:POM), a leading online medical services platform for chronic diseases in China, today announced that it has received a written notification (the "Deficiency Letter") from the staff of the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") dated January 29, 2026, indicating that for the last 33 consecutive business days, the closing bid price of the Company's American depositary shares (the "ADSs") was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5450(a)(1). The Deficiency Letter has no current effect on the listing o

6-K - POMDOCTOR Ltd (0001877971) (Filer)

GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ:POM), a leading online medical services platform for chronic diseases in China, today announced significant progress in its strategic collaboration with leading domestic pharmaceutical companies to accelerate the growth of its internet hospital business. The Company expects these partnerships to become a core component of its long-term strategy to expand online hospital operations and enhance overall profitability. Against the backdrop of China's accelerating population aging and evolving demographic structure, the domestic internet hospital and online pharmaceutical sales market has exp